Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 80

Sort by

Sort Order Select

Journal Articles

Bone Marrow Harvest Volume and CD34+ Cell Count in Pediatric Sibling Donors: A Single Centre Retrospective Analysis

Awatif Alanazi, MD, Amir Nadeem, Khawar Siddiqui, Mouhab Ayas, MD, Ali Abdallah Ahmari, MD, Ibrahim A. Ghemlas, MD, Abdullah Aljefri, MD, Hawazen S. Alsaedi, MD, Amal Al-Seraihy, MD

Blood (2019) 134 (Supplement_1): 1969.

https://doi.org/10.1182/blood-2019-127655

Published: 2019

Journal Articles

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Locke J. Bryan, MD, Scott E. Smith, MD PhD, Pamela Allen, MDMSc, Carla Casulo, Brett Alan Palmer, BS, Reem Karmali, MD, Barbara Pro, MD, Denise M Scholtens, PhD, Hatice Savas, MD, Jayesh Mehta, MD, Leo I. Gordon, MD, Jane N. Winter, MD

Blood (2019) 134 (Supplement_1): 4029.

https://doi.org/10.1182/blood-2019-123879

Published: 2019

Journal Articles

Peripheral Blood to Marrow Collection White Cell Count Ratio As an Indicator of Harvest Quality and Transplant Outcomes in G-CSF-Primed Marrow Grafts

Rajat Kumar Agarwal, BE, Rakesh Dhanya, BE, Stalin Ramprakash, MD MBBS, C P Raghuram, MD, Pallavi Mehta, MD DM, Deepa Trivedi, MD, Shruthi Jayapal, Sandeep S, Lawrence Faulkner, MD

Blood (2019) 134 (Supplement_1): 4473.

https://doi.org/10.1182/blood-2019-125111

Published: 2019

Journal Articles

Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy

Blood (2019) 134 (Supplement_1): 3358.

https://doi.org/10.1182/blood-2019-127393

Published: 2019

Journal Articles

Robust Cell Selections and Depletions across Various Hematopoietic Cell Fractions on the Clinimacs Plus Instrument

Thejaswi Bikkani, MBBS, Katherine Li, Anusha Rao, Angela Pickett, Xiaobai Li, PhD, Minoo Battiwalla, MD, Richard W. Childs, MD, John Barrett, MD, Andre Larochelle, MD PhD, Elizabeth Kang, MD, David F. Stroncek, Sandhya R. Panch, MD MPH

Blood (2018) 132 (Supplement 1): 3818.

https://doi.org/10.1182/blood-2018-99-118582

Published: 2018

Journal Articles

Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases

Hafiz Muhammad Fazeel, MD, Muhammad Abu Zar, MD, Saad Ullah Malik, MD, Ahmad Kamal, MD, Mustafa Nadeem Malik, MD, Syed Shabee Hassan, MD, Syeda Sabeeka Batool, MD, Ceren Durer, MD, Seren Durer, MD, Shehroz Aslam, MD, Madeeha Shafqat, Faiqa Ijaz, MBBS, Faiz Anwer, MD, Shahrukh K. Hashmi, MDMPH

Blood (2018) 132 (Supplement 1): 2194.

https://doi.org/10.1182/blood-2018-99-114511

Published: 2018

Journal Articles

Single-Cell RNA-Seq Analysis of Native Murine Megakaryocytes from Young and Old Mice Reveals Significant Metabolic and Mitochondrial Differences throughout Megakaryocyte Development

Pavel Davizon-Castillo, MD, Kenneth L. Jones, PhD, George D Trahan, MS, Jorge Di Paola, MD

Blood (2018) 132 (Supplement 1): 1286.

https://doi.org/10.1182/blood-2018-99-120006

Published: 2018

Journal Articles

Gene Therapy for Sickle Cell Anemia Using a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant Shows Promising Correction of the Disease Phenotype

Blood (2018) 132 (Supplement 1): 1021.

https://doi.org/10.1182/blood-2018-99-119591

Published: 2018

Journal Articles

Genotypic Representation of Myelodysplastic/Myeloproliferative Neoplasms in Nrg, Nrg-3GS and Srg-W41 Mice with Transgenic Expression of Human Cytokines

Hein Than, MD FRCPath, MRCP, Naoto Nakamichi, MD PhD, Anthony D. Pomicter, MS, John O'Shea, PhD, Orlando Antelope, Thomas O'Hare, PhD, Connie J. Eaves, PhD, Michael W. Deininger, MD PhD

Blood (2018) 132 (Supplement 1): 2038.

https://doi.org/10.1182/blood-2018-99-111728

Published: 2018

Journal Articles

CD31 Expression Defines Heterogeneity of Donor Plasmacytoid Dendritic Cell Populations That Home to the Thymus: Implications for Control of GvHD

Alina Ulezko Antonova, Yitong Wang, MD, Mojibade Hassan, Yiwen Li, Edmund K. Waller, MD

Blood (2018) 132 (Supplement 1): 3325.

https://doi.org/10.1182/blood-2018-99-113047

Published: 2018

Journal Articles

Genomic Discovery and Clonal Tracking in Multiple Myeloma By Cell Free DNA Sequencing

Blood (2017) 130 (Supplement 1): 329.

https://doi.org/10.1182/blood.V130.Suppl_1.329.329

Published: 2017

Journal Articles

Outcome and Factors Affecting Survival of Childhood Myelodysplastic Syndrome: Single Centre Experience

Amr A. Dahdouh, MD, Mahmoud Hammad, MD, Hanafy Hafez, MDPhD, Sherine Salem, Sonya Soliman, MD, Salma Ghazal, Omayma Hassanain, Alaa M. Elhaddad, MD PhD

Blood (2017) 130 (Supplement 1): 5309.

https://doi.org/10.1182/blood.V130.Suppl_1.5309.5309

Published: 2017

Journal Articles

Inability to Complete the Second of Planned Tandem Autologous Stem Cell Transplantations for Metastatic Germ Cell Tumors: Reasons, Toxicity and Impact on Outcomes

Praful Ravi, MA, MBBChir, MRCP, Mark Lewis, MD, Taxiarchis Kourelis, MD, Stephen M Ansell, MD PhD, Brian Costello, MD, J. Fernando Quevedo, MD, Manish Kohli, MD, Roxana S. Dronca, MD, Alan Bryce, MD, Mark R. Litzow, MD, Lance Pagliaro, MD, Mrinal M. Patnaik, MDMBBS

Blood (2017) 130 (Supplement 1): 4547.

https://doi.org/10.1182/blood.V130.Suppl_1.4547.4547

Published: 2017

Journal Articles

Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy

Blood (2017) 130 (Supplement 1): 4609.

https://doi.org/10.1182/blood.V130.Suppl_1.4609.4609

Published: 2017

Journal Articles

Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

Julie Kanter, MD, Mark C. Walters, MD, Matthew Hsieh, MD, Lakshmanan Krishnamurti, MD, Janet L. Kwiatkowski, MD, Rammurti Kamble, MD, Christof von Kalle, MD, Marcelyne Joseney-Antoine, Francis J. Pierciey, Jr., Weiliang Shi, PhD, Mohammed Asmal, MD PhD, Alexis A Thompson, MD MPH, John F Tisdale, MD

Blood (2017) 130 (Supplement 1): 527.

https://doi.org/10.1182/blood.V130.Suppl_1.527.527

Published: 2017

Journal Articles

Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

Julie Kanter, MD, Mark C. Walters, MD, Matthew M. Hsieh, MD, Lakshmanan Krishnamurti, MD, Janet Kwiatkowski, MD, Rammurti T Kamble, MD, Christof von Kalle, MD, Frans A. Kuypers, PhD, Marina Cavazzana, MD PhD, Philippe Leboulch, MD, Marcelyne Joseney-Antoine, Mohammed Asmal, MD PhD, Alexis A. Thompson, MD MPH, John F. Tisdale, MD

Blood (2016) 128 (22): 1176.

https://doi.org/10.1182/blood.V128.22.1176.1176

Published: 2016

Journal Articles

Update from the Hgb-205 Phase 1/2 Clinical Study of Lentiglobin Gene Therapy: Sustained Clinical Benefit in Severe Hemoglobinopathies

Blood (2016) 128 (22): 2311.

https://doi.org/10.1182/blood.V128.22.2311.2311

Published: 2016

Journal Articles

Haploidentical Transplantation for DOCK8 Deficiency

Nirali N Shah, MD, Alexandra F Freeman, MD, Mark Parta, MD, Helen Su, MD PhD, Gulbu Uzel, MD, Juan C. Gea-Banacloche, MD, Steven M. Holland, MD, Dennis D. Hickstein, MD

Blood (2015) 126 (23): 2229.

https://doi.org/10.1182/blood.V126.23.2229.2229

Published: 2015

Journal Articles

Outcomes of Gene Therapy for Severe Sickle Disease and Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral Beta AT87Q-Globin Vector

Blood (2015) 126 (23): 202.

https://doi.org/10.1182/blood.V126.23.202.202

Published: 2015

Journal Articles

Preoperative Autologous Blood Collection for Bone Marrow Harvests: Is It Justified?

Komal Arora, MD, Fernando Martinez, MD MPH, Blanca N Keneson, SBB(ASCP), Benjamin Lichtiger, MD PhD

Blood (2015) 126 (23): 4739.

https://doi.org/10.1182/blood.V126.23.4739.4739

Published: 2015

NARROW

Bone Marrow Harvest Volume and CD34+ Cell Count in Pediatric Sibling Donors: A Single Centre Retrospective Analysis

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Peripheral Blood to Marrow Collection White Cell Count Ratio As an Indicator of Harvest Quality and Transplant Outcomes in G-CSF-Primed Marrow Grafts

Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy

Robust Cell Selections and Depletions across Various Hematopoietic Cell Fractions on the Clinimacs Plus Instrument

Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases

Single-Cell RNA-Seq Analysis of Native Murine Megakaryocytes from Young and Old Mice Reveals Significant Metabolic and Mitochondrial Differences throughout Megakaryocyte Development

Gene Therapy for Sickle Cell Anemia Using a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant Shows Promising Correction of the Disease Phenotype

Genotypic Representation of Myelodysplastic/Myeloproliferative Neoplasms in Nrg, Nrg-3GS and Srg-W41 Mice with Transgenic Expression of Human Cytokines

CD31 Expression Defines Heterogeneity of Donor Plasmacytoid Dendritic Cell Populations That Home to the Thymus: Implications for Control of GvHD

Genomic Discovery and Clonal Tracking in Multiple Myeloma By Cell Free DNA Sequencing

Outcome and Factors Affecting Survival of Childhood Myelodysplastic Syndrome: Single Centre Experience

Inability to Complete the Second of Planned Tandem Autologous Stem Cell Transplantations for Metastatic Germ Cell Tumors: Reasons, Toxicity and Impact on Outcomes

Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy

Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

Update from the Hgb-205 Phase 1/2 Clinical Study of Lentiglobin Gene Therapy: Sustained Clinical Benefit in Severe Hemoglobinopathies

Haploidentical Transplantation for DOCK8 Deficiency

Outcomes of Gene Therapy for Severe Sickle Disease and Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral Beta AT87Q-Globin Vector

Preoperative Autologous Blood Collection for Bone Marrow Harvests: Is It Justified?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only